Aim: Oxidative stress has long been considered as a major contributing factor in the pathogenesis of Parkinson's disease. However, molecular sources for reactive oxygen species in Parkinson's disease have not been clearly elucidated. Herein, we sought to investigate whether a superoxide-producing NADPH oxidases (NOXs) are implicated in oxidative stress-mediated dopaminergic neuronal degeneration. Results: Expression of various Nox isoforms and cytoplasmic components were investigated in N27, rat dopaminergic cells. While most of Nox isoforms were constitutively expressed, Nox1 expression was significantly increased after treatment with 6-hydroxydopamine. Rac1, a key regulator in the Nox1 system, was also activated. Striatal injection of 6-hydroxydopamine increased Nox1 expression in dopaminergic neurons in the rat substantia nigra. Interestingly, it was localized into the nucleus, and immunostaining for DNA oxidative stress marker, 8-oxo-dG, was increased. Nox1expression was also found in the nucleus of dopaminergic neurons in the substantia nigra of Parkinson's disease patients. Adeno-associated virus-mediated Nox1 knockdown or Rac1 inhibition reduced 6-hydroxydopamine-induced oxidative DNA damage and dopaminergic neuronal degeneration significantly. Innovation: Nox1/Rac1 could serve as a potential therapeutic target for Parkinson's disease. Conclusion: We provide evidence that dopaminergic neurons are equipped with the Nox1/Rac1 superoxide-generating system. Stress-induced Nox1/Rac1 activation causes oxidative DNA damage and neurodegeneration. Reduced dopaminergic neuronal death achieved by targeting Nox1/Rac1, emphasizes the impact of oxidative stress caused by this system on the pathogenesis and therapy in Parkinson's disease. Antioxid. Redox Signal. 16, 1033–1045.
Get full access to this article
View all access options for this article.
References
1.
AkbariM, OtterleiM, Pena-DiazJ, KrokanHE. Different organization of base excision repair of uracil in DNA in nuclei and mitochondria and selective upregulation of mitochondrial uracil-DNA glycosylase after oxidative stress. Neuroscience, 145:1201–1212. 2007.
2.
AlamZI, JennerA, DanielSE, LeesAJ, CairnsN, MarsdenCD, JennerP, HalliwellB. Oxidative DNA damage in the parkinsonian brain: An apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem, 69:1196–1203. 1997.
3.
AnantharamV, KaulS, SongC, KanthasamyA, KanthasamyAG. Pharmacological inhibition of neuronal NADPH oxidase protects against 1-methyl-4-phenylpyridinium (MPP+)-induced oxidative stress and apoptosis in mesencephalic dopaminergic neuronal cells. Neurotoxicology, 28:988–997. 2007.
4.
BanfiB, ClarkRA, StegerK, KrauseKH. Two novel proteins activate superoxide generation by the NADPH oxidase NOX1. J Biol Chem, 278:3510–3513. 2003.
5.
BedardK, KrauseKH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev, 87:245–313. 2007.
6.
BehrensMM, AliSS, DaoDN, LuceroJ, ShekhtmanG, QuickKL, DuganLL. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science, 318:1645–1647. 2007.
7.
BenderA, KrishnanKJ, MorrisCM, TaylorGA, ReeveAK, PerryRH, JarosE, HershesonJS, BettsJ, KlopstockT, TaylorRW, TurnbullDM. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet, 38:515–517. 2006.
8.
BjorklundA, KirikD, RosenbladC, GeorgievskaB, LundbergC, MandelRJ. Towards a neuroprotective gene therapy for Parkinson's disease: Use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model. Brain Res, 886:82–98. 2000.
9.
BokochGM, DieboldBA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood, 100:2692–2696. 2002.
10.
ChamulitratW, SchmidtR, TomakidiP, StremmelW, ChunglokW, KawaharaT, RokutanK. Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene, 22:6045–6053. 2003.
11.
ChengG, CaoZ, XuX, van MeirEG, LambethJD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene, 269:131–140. 2001.
12.
ChoiDH, KimYJ, KimYG, JohTH, BealMF, KimYS. Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death. J Biol Chem, 286:14168–14177. 2011.
13.
CristovaoAC, ChoiDH, BaltazarG, BealMF, KimYS. The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal, 11:2105–2118. 2009.
14.
DaiberA. Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta, 1797:897–906. 2010.
15.
De DekenX, WangD, ManyMC, CostagliolaS, LibertF, VassartG, DumontJE, MiotF. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem, 275:23227–23233. 2000.
16.
DesoukiMM, KulawiecM, BansalS, DasGM, SinghKK. Cross talk between mitochondria and superoxide generating NADPH oxidase in breast and ovarian tumors. Cancer Biol Ther, 4:1367–1373. 2005.
17.
EdensWA, SharlingL, ChengG, ShapiraR, KinkadeJM, LeeT, EdensHA, TangX, SullardsC, FlahertyDB, BenianGM, LambethJD. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol, 154:879–891. 2001.
18.
FanCY, KatsuyamaM, Yabe-NishimuraC. PKCdelta mediates up-regulation of NOX1, a catalytic subunit of NADPH oxidase, via transactivation of the EGF receptor: Possible involvement of PKCdelta in vascular hypertrophy. Biochem J, 390:761–767. 2005.
19.
GeisztM, LekstromK, BrennerS, HewittSM, DanaR, MalechHL, LetoTL. NAD(P)H oxidase 1, a product of differentiated colon epithelial cells, can partially replace glycoprotein 91phox in the regulated production of superoxide by phagocytes. J Immunol, 171:299–306. 2003.
20.
GeisztM, LekstromK, WittaJ, LetoTL. Proteins homologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem, 278:20006–20012. 2003.
GordilloG, FangH, ParkH, RoyS. Nox-4-dependent nuclear H2O2 drives DNA oxidation resulting in 8-OHdG as urinary biomarker and hemangioendothelioma formation. Antioxid Redox Signal, 12:933–943.
23.
HilenskiLL, ClempusRE, QuinnMT, LambethJD, GriendlingKK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol, 24:677–683. 2004.
24.
InfangerDW, SharmaRV, DavissonRL. NADPH oxidases of the brain: Distribution, regulation, and function. Antioxid Redox Signal, 8:1583–1596. 2006.
25.
KatsuyamaM, FanC, ArakawaN, NishinakaT, MiyagishiM, TairaK, Yabe-NishimuraC. Essential role of ATF-1 in induction of NOX1, a catalytic subunit of NADPH oxidase: Involvement of mitochondrial respiratory chain. Biochem J, 386:255–261. 2005.
26.
KawaharaT, KohjimaM, KuwanoY, MinoH, Teshima-KondoS, TakeyaR, TsunawakiS, WadaA, SumimotoH, RokutanK. Helicobacter pylori lipopolysaccharide activates Rac1 and transcription of NADPH oxidase Nox1 and its organizer NOXO1 in guinea pig gastric mucosal cells. Am J Physiol Cell Physiol, 288:C450–457. 2005.
27.
KurodaJ, NakagawaK, YamasakiT, NakamuraK, TakeyaR, KuribayashiF, Imajoh-OhmiS, IgarashiK, ShibataY, SueishiK, SumimotoH. The superoxide-producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells. Genes Cells, 10:1139–1151. 2005.
28.
LeeSB, BaeIH, BaeYS, UmHD. Link between mitochondria and NADPH oxidase 1 isozyme for the sustained production of reactive oxygen species and cell death. J Biol Chem, 281:36228–36235. 2006.
MichaelsonD, AbidiW, GuardavaccaroD, ZhouM, AhearnI, PaganoM, PhilipsMR. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol, 181:485–496. 2008.
31.
MiglioreL, PetrozziL, LucettiC, GambacciniG, BernardiniS, ScarpatoR, TrippiF, BaraleR, FrenzilliG, RodillaV, BonuccelliU. Oxidative damage and cytogenetic analysis in leukocytes of Parkinson's disease patients. Neurology, 58:1809–1815. 2002.
32.
NakabeppuY, TsuchimotoD, YamaguchiH, SakumiK. Oxidative damage in nucleic acids and Parkinson's disease. J Neurosci Res, 85:919–934. 2007.
33.
NikolovaS, LeeYS, KimJA. Rac1-NADPH oxidase-regulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic Res, 39:1295–1304. 2005.
34.
NouspikelT. DNA repair in differentiated cells: Some new answers to old questions. Neuroscience, 145:1213–1221. 2007.
35.
PrasadKN, CarvalhoE, KentrotiS, Edwards-PrasadJ, FreedC, VernadakisA. Establishment and characterization of immortalized clonal cell lines from fetal rat mesencephalic tissue. In Vitro Cell Dev Biol Anim, 30A:596–603. 1994.
36.
QinB, CartierL, Dubois-DauphinM, LiB, SerranderL, KrauseKH. A key role for the microglial NADPH oxidase in APP-dependent killing of neurons. Neurobiol Aging, 27:1577–1587. 2006.
37.
Rodriguez-LebronE, Denovan-WrightEM, NashK, LewinAS, MandelRJ. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol Ther, 12:618–633. 2005.
38.
Rodriguez-PallaresJ, PargaJA, MunozA, ReyP, GuerraMJ, Labandeira-GarciaJL. Mechanism of 6-hydroxydopamine neurotoxicity: The role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons. J Neurochem, 103:145–156. 2007.
39.
RossiF, ZattiM. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia, 20:21–23. 1964.
40.
SchapiraAH, CooperJM, DexterD, JennerP, ClarkJB, MarsdenCD. Mitochondrial complex I deficiency in Parkinson's disease. Lancet, 1:1269. 1989.
SilvaRM, KuanCY, RakicP, BurkeRE. Mixed lineage kinase-c-jun N-terminal kinase signaling pathway: A new therapeutic target in Parkinson's disease. Mov Disord, 20:653–664. 2005.
43.
SorceS, KrauseKH. NOX enzymes in the central nervous system: From signaling to disease. Antioxid Redox Signal, 11:2481–2504. 2009.
44.
StolkJ, HiltermannTJ, DijkmanJH, VerhoevenAJ. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am J Respir Cell Mol Biol, 11:95–102. 1994.
45.
SuhYA, ArnoldRS, LassegueB, ShiJ, XuX, SorescuD, ChungAB, GriendlingKK, LambethJD. Cell transformation by the superoxide-generating oxidase Mox1. Nature, 401:79–82. 1999.
46.
UeyamaT, LekstromK, TsujibeS, SaitoN, LetoTL. Subcellular localization and function of alternatively spliced Noxo1 isoforms. Free Radic Biol Med, 42:180–190. 2007.
47.
Van der PerrenA, ToelenJ, CarlonM, Van den HauteC, CounF, HeemanB, ReumersV, VandenbergheLH, WilsonJM, DebyserZ, BaekelandtV. Efficient and stable transduction of dopaminergic neurons in rat substantia nigra by rAAV 2/1, 2/2, 2/5, 2/6.2, 2/7, 2/8 and 2/9. Gene Ther, 18:517–527. 2011.
48.
WestMJ, GundersenHJ. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol, 296:1–22. 1990.
49.
WosniakJJ, SantosCX, KowaltowskiAJ, LaurindoF. Cross-talk between mitochondria and NADPH oxidase: Effects of mild mitochondrial dysfunction on angiotensin II mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. Antioxid Redox Signal, 11:1265–1278. 2009.
50.
WuDC, TeismannP, TieuK, VilaM, Jackson-LewisV, IschiropoulosH, PrzedborskiS. NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Proc Natl Acad Sci USA, 100:6145–6150. 2003.
51.
ZekryD, EppersonTK, KrauseKH. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia?IUBMB Life, 55:307–313. 2003.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
